Market capitalization | $1.35b |
Enterprise Value | $1.29b |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 3.30 |
P/S ratio (TTM) P/S ratio | 3.47 |
P/B ratio (TTM) P/B ratio | 5.41 |
Revenue growth (TTM) Revenue growth | 22.10% |
Revenue (TTM) Revenue | $389.96m |
As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.
17 Analysts have issued a Phreesia Inc forecast:
17 Analysts have issued a Phreesia Inc forecast:
Jul '24 |
+/-
%
|
||
Revenue | 390 390 |
22%
22%
|
|
Gross Profit | 230 230 |
33%
33%
|
|
EBITDA | -65 -65 |
48%
48%
|
EBIT (Operating Income) EBIT | -96 -96 |
38%
38%
|
Net Profit | -100 -100 |
34%
34%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Phreesia, Inc. provides patient check-in solutions for medical practices. It provides solutions that transform the healthcare experience by engaging patients in their care and enabling healthcare provider organizations to optimize operational efficiency, improve profitability and enhance clinical care. Through the SaaS-based Phreesia Platform the company offers healthcare provider organizations a robust suite of solutions to manage the patient intake process and a payments solution for secure processing of patient payments. Its platform also provides life sciences companies with an engagement channel for targeted and direct communication with patients. Phreesia was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in New York, NY.
Head office | United States |
CEO | Chaim Indig |
Employees | 1,438 |
Founded | 2005 |
Website | www.phreesia.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.